PNC Financial Services Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
DTC
FCM
BBA
TCM
PNC Financial Services Group's IMVT Position: Q2 2026 in Review
PNC Financial Services Group increased its Immunovant (IMVT) stake by 0.69% in Q2 2026, buying an estimated $609 and bringing the position to 2,922 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2841.
PNC Financial Services Group first reported a position in IMVT in Q3 2021 and has held it in 18 quarters since. The position peaked at $809K in Q4 2022. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.
- PNC Financial Services Group held 2,922 shares of Immunovant worth $113K as of Q2 2026.
- PNC Financial Services Group bought 20 Immunovant shares in Q2 2026, an estimated $609.
- Immunovant made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2841 holding.
- PNC Financial Services Group first reported a position in Immunovant in Q3 2021 and has held it in 18 quarters since.
- PNC Financial Services Group's Immunovant position peaked at $809K in Q4 2022.
- 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.